Cameron MacDonald

Cameron MacDonald  


Executive Summary

Cameron MacDonald is a partner in the Toronto office of Borden Ladner Gervais LLP and a member of the Securities and Capital Markets Group. His practice focuses on corporate and securities law, with an emphasis on corporate finance and mergers and acquisitions, as well as the structuring and distribution of public and private investment funds and structured products.

Cameron regularly advises foreign and domestic clients on complex capital markets transactions, including RTOs, IPOs, qualifying transactions, new issues, secondary offerings and private placements for TSX, TSX-V and CSE listed issuers across a broad range of industries, including cannabis, diversified, financial services, healthcare, mining, and oil and gas.

He has also represented public and private companies, private equity sponsors, special committees, boards, financial advisers and other transaction participants involved in a variety of M&A transactions, including both friendly and hostile transactions.

Cameron was recognized as one of Canada’s Top 40 Lawyers under 40 by Lexpert in 2015.

Representative Work


  • The agents, led by Beacon Securities Limited, in connection with the C$50M private placement offering by Cannex Capital Group Inc. of subscription receipts to fund its acquisition of BrightLeaf Development LLC and concurrent reverse take-over of Arco Resources Corp.
  • The underwriters in connection with Superior Plus LP's C$250 million offering of 5.25% Senior Unsecured Notes
  • The underwriters, led by CIBC Capital Markets and Scotiabank, in connection with Superior Plus LP's C$250M offering of 5.25% senior unsecured notes and the C$150M reopening, led by National Bank Financial Markets and CIBC Capital Markets, to finance the redemption of its 6.00% convertible unsecured debentures
  • The underwriters, led by Scotia Capital Inc. and National Bank Financial Inc. in connection with the C$300M bought deal private placement by CES Energy Solutions Corp. of 6.375% senior unsecured notes due 2024
  • Scotia Capital Inc. in the combined sale of shares of TMX Group Ltd. held by each of Scotia Capital and Alberta Investment Management Corporation, representing 9.9% overall of the issued and outstanding shares of TMX for aggregate proceeds of C$368M
  • AIMCo Realty Investors LP in its C$400M private placement offering of 2.266% Senior Unsecured Notes, Series 1, due 2024
  • Algoma Central Corporation in its substantial issuer bid to purchase for cancellation up to C$20M of its common shares for cash by way of a "modified Dutch auction"
  • Algoma Central Corporation in its C$82.5M offering of convertible unsecured subordinated debentures
  • VBI Vaccines Inc., as Canadian counsel, in its underwritten public offering and concurrent registered direct offering of common shares for aggregate gross proceeds of approximately US$71.9M
  • CaféX Communications Inc., as Canadian counsel, in its acquisition of Vayyoo Inc.
  • Manulife's $2.26 billion equity financing to fund its $4 billion acquisition of Standard Life plc's Canadian-based operations, including its $1.76 billion public offering and concurrent $500 million private placement to La Caisse de dépôt et placement du Québec
  • Manulife's offering in Taiwan of U.S.$1 billion principal amount of 4.70% senior notes due June 23, 2046
  • Manulife's offering in Singapore of 500 million Singapore dollars principal amount of 3.85% subordinated notes due May 25, 2026
  • $1 billion offering by The Manufacturers Life Insurance Company of 3.181% fixed/floating subordinated debentures
  • $113 million initial public offering of the Manulife U.S. Regional Bank Trust
  • $283 million initial public offering of the Manulife Floating Rate Senior Loan Fund
  • Goldman Sachs in connection with its launch of the SIGMA X Canada dark pool ATS
  • McCain Capital Corporation and Michael Harrison McCain in connection with various corporate reorganizations involving McCain Foods Group Inc. and Maple Leaf Foods Inc.
  • Cara Operations Limited in its consent solicitation and subsequent $75 million private placement of debt subscription receipts
  • Carl C. Icahn and affiliates in their dual compliant multiple take-over bids and tender offers for the common shares of Lions Gate Entertainment Corp. and their proxy contest for the election of directors of Lions Gate
  • Dyadem International Limited in connection with its acquisition by IHS Inc. by way of statutory arrangement
  • Angiotech Pharmaceuticals Inc. in connection with its CCAA restructuring proceedings
  • Fiera Capital Inc. in its $245 million reverse take-over acquisition of Sceptre Investment Counsel Limited by way of statutory plan of arrangement
  • Walton Global Investments in its sale of Titan Funds Incorporated and Partners In Planning Financial Group Ltd. to Investment Planning Counsel Inc.
  • United Natural Foods Inc. in its acquisition of the SunOpta distribution group
  • The agents, led by GMP Securities L.P. and Byron Securities Limited, in the $58 million public offering of common shares of Rare Element Resources Ltd.
  • The underwriters, led by RBC Dominion Securities Inc., in the $390 million secondary offering by Hochschild Mining plc and Hochschild Mining Holdings Limited of common shares of Lake Shore Gold Corp.
  • Dundee REIT in its $115 million bought deal offering of units